Showing results (1841-1850 of 2,016) with videos related to
Sort By:
Pageof 202
Frontiers in Immunology|December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphomaLilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.Lancet (London, England)|January 18, 2011
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studiesMuredach P Reilly, Mingyao Li, Jing He, et al.Nature Communications|June 26, 2015
Lucilia cuprina genome unlocks parasitic fly biology to underpin future interventionsClare A Anstead, Pasi K Korhonen, Neil D Young, et al.JAMA|July 2, 2009
Genetic Loci associated with C-reactive protein levels and risk of coronary heart diseasePaul Elliott, John C Chambers, Weihua Zhang, et al.Cancer Cell|July 16, 2014
Hematogenous metastasis of ovarian cancer: rethinking mode of spreadSunila Pradeep, Seung W Kim, Sherry Y Wu, et al.Circulation. Cardiovascular Genetics|October 7, 2010
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controlsMichael Preuss, Inke R König, John R Thompson, et al.Journal of the American College of Cardiology|December 24, 2016
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) LevelsConnor A Emdin, Amit V Khera, Pradeep Natarajan, et al.Nature Genetics|October 30, 2012
Bayesian refinement of association signals for 14 loci in 3 common diseases, Julian B Maller, Gilean McVean, et al.Nature Ecology & Evolution|July 27, 2025
Neighbourhood diversity increases tree growth in experimental forests more in wetter climates but not in wetter yearsLiting Zheng, Inés Ibáñez, Laura J Williams, et al.Transplantation and Cellular Therapy|December 20, 2025
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patientsLilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, et al.Pageof 202